Home » Topics » Regulatory » EMA

EMA
RSS

EMA accepts Genzyme's teriflunomide MAA

Feb. 24, 2012

EMA grants new marketing approval for dry powder inhaler

Feb. 24, 2012

CHMP requests additional information on Glybera

Feb. 21, 2012

EMA adopts scientific opinion on Pyramax

Feb. 21, 2012

CHMP issues opinion on Humira in ulcerative colitis

Feb. 21, 2012

CHMP recommends approval of Byetta line extension

Feb. 20, 2012

EMA committee recommends conditional approval of Pixuvri

Feb. 20, 2012

New approval for Zelboraf

Feb. 20, 2012

GlaxoSmithKline receives CHMP opinion on Nimenrix

Feb. 20, 2012

Novartis to revise product information for Rasilez in the E.U.

Feb. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...